Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Short-term culture of tumour slices reveals the heterogeneous sensitivity of human head and neck squamous cell carcinoma to targeted therapies

Fig. 5

Correlation analysis exploring the mode of action of targeted therapies against HSNCC. A correlation is presented between the % reduction of Ki67 labelling induced by erlotinib (a) and tivantinib (b), and the % reduction of the pERK/ERK ratio. Each dot represents a single patient. Values of Pearson’s r test and the corresponding p value are presented each time

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us